The White House–Scene of COVID Outbreaks under Trump–Will Get a Deep Clean for President-Elect Biden
Fears about lingering coronavirus are prompting a massive disinfection initiative before the Bidens move in -- Read more on ScientificAmerican.com
Fears about lingering coronavirus are prompting a massive disinfection initiative before the Bidens move in -- Read more on ScientificAmerican.com
Hospital robes, facemasks and other garments needn't be drab—and a bit of flair can actually make people feel measurably better -- Read more on ScientificAmerican.com
There’s finally a plan for how to do that -- Read more on ScientificAmerican.com
There’s finally a plan for how to do that -- Read more on ScientificAmerican.com
Kidney disease affects millions of Americans, but corporate capture of dialysis, along with disparities in treatment and transplant access, mean that not everyone's journey is the same. -- Read more on ScientificAmerican.com
Pandemic highlights for the week -- Read more on ScientificAmerican.com
Treatments that reduce suffering and incorporate patient values aren’t common in kidney disease care. That’s changing. -- Read more on ScientificAmerican.com
Demand for healthy kidneys has long outstripped supply. But better testing and treatment is expanding the donor pool. -- Read more on ScientificAmerican.com
With the festive season ahead, Nature examines what is known about the risks of COVID spread, and how researchers will spend their time off -- Read more on ScientificAmerican.com
Emergency use authorizations by the FDA are not ideal -- Read more on ScientificAmerican.com
Minority patients are diagnosed later, stay on dialysis longer, and are added to transplant lists less quickly. Why? -- Read more on ScientificAmerican.com
Joint ventures between nephrologists and dialysis centers have expanded treatment. Critics ask: At what cost? -- Read more on ScientificAmerican.com
Kidney disease affects millions of Americans, but corporate capture of dialysis, along with disparities in treatment and transplant access, mean that not everyone's journey is the same. On this... -- Read more on ScientificAmerican.com
Kidney disease affects millions of Americans, but corporate capture of dialysis, along with disparities in treatment and transplant access, mean that not everyone's journey is the same. On this... -- Read more on ScientificAmerican.com
A new California law aims to curb what sponsors say is profiteering by dialysis centers. But are there any easy answers? -- Read more on ScientificAmerican.com
A new California law aims to curb what sponsors say is profiteering by dialysis centers. But are there any easy answers? -- Read more on ScientificAmerican.com